Radiation abscopal antitumor effect is mediated through p53

Cancer Research

Volumn 63, Issue 8, 2003, Pages 1990-1993

  Camphausen, Kevin ^a   Moses, Marsha A ^b,c   Ménard, Cynthia ^a   Sproull, Mary ^a   Beecken, Wolf Dietrich ^e   Folkman, Judah ^b,c   O'Reilly, Michael S ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PIFITHRIN ALPHA; PROTEIN INHIBITOR; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; FIBROSARCOMA; IRRADIATION; LEG; LEWIS CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIATION; RADIATION DOSE; TREATMENT OUTCOME; TUMOR GROWTH; UPREGULATION; WILD TYPE;

ANIMALS; CARCINOMA, LEWIS LUNG; FIBROSARCOMA; MALE; MICE; MICE, INBRED C57BL; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0345269096     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Mole, R. H. Whole body irradiation-radiobiology or medicine? Br. J. Radiol., 26: 234-241, 1953.
2. Nobler, M. The abscopal effect in malignant lymphoma and its relationship to lymphocyte circulation. Radiology, 93: 410-412, 1969.
3. Antoniades, J., Brady, L., and Lightfoot, D. Lymphangiographic demonstration of the abscopal effect in patients with malignant lymphomas. Int. J. Radiat. Oncol. Biol. Phys., 2: 141-147, 1977.
4. Rees, G. J. Abscopal regression in lymphoma: a mechanism in common with total body irradiation? Clin. Radiol., 32: 475-480, 1981.
5. Ehlers, G., and Fridman, M. Abscopal effect of radiation in papillary adenocarcinoma. Br. J. Radiol., 46: 220-222, 1973.
6. Kingsley, D. An interesting case of possible abscopal effect in malignant melanoma. Br. J. Radiol., 48: 863-866, 1975.
7. Rees, G., and Ross, C. Abscopal regression following radiotherapy for adenocarcinoma. Br. J. Radiol., 56: 63-66, 1983.
8. Sham, R. The abscopal effect and chronic lymphocytic leukemia. Am. J. Med., 98: 307-308, 1995.
9. Ohba, K., Omagari, K., Nakamura, T., Ikuno, N., Saeki, S., Matsuo, I., Kinoshita, H., Masuda, J., Hazama, H., Sakamoto, I., and Kohno, S. Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Gut, 43: 575-577, 1998.
10. Uchida, A., Mizutani, Y., Nagamuta, M., and Ikenaga, M. Elevation of sensitivity of tumor cells and lytic function of NK cells. Immunopharmacol. Immunotoxicol., 11: 507-519, 1989.
11. O'Reilly, M., Holmgren, L., Chen, C., and Folkman, J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med., 2: 689-692, 1996.
12. O'Reilly, M., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R., Moses, M., Lane, w., Cao, Y., Sage, H., and Folkman, J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by Lewis lung carcinoma. Cell, 79: 315-328, 1994.
13. Jacks, T., Remington, L., Williams, B., Schmitt, E., Halachmi, S., Bronson, R., and Weinberg, R. Tumor spectrum analysis in p53-mutant mice. Curr. Biol., 4: 1-7, 1994.
14. Rizzo, M., Soddu, S., Tibursi, G., Calabretta, B., and Sacchi, A. Wild-type p53 differentially affects tumorigenic and metastatic potential of murine metastatic cell variants. Clin. Exp. Metastasis, 11: 368-376, 1993.
15. Komarov, P., Komarova, E., Kondratov, R., Christov-Tselkov, K., Coon, J., Chernov, M., and Gudkov, A. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science (Wash. DC), 285: 1733-1737, 1999.
16. Jolles, B., and Harrison, R. G. Radiation skin reaction and depletion and restoration of body immune response. Nature (Lond.). 198: 1216-1217, 1963.
17. Hall, E. Radiobiology for the radiologist, Ed. 5, p. 588. Philadelphia: Lippincott, Williams and Wilkins, 2000.
18. Trott, K. R. Non-targeted radiation effects in radiotherapy-roles of radiation-induced genomic instability and of the bystander effect in cancer cure by radiotherapy. Acta Oncologia, 40: 976-980, 2001.
19. Hartford, A., Gohongi, T., Fukumura, D., and Jain, R. Irradiation of a primary tumor, unlike surgical removal, enhances angiogenesis suppression at a distal site: potential role of host-tumor interaction. Cancer Res., 60: 2128-2131, 2000.
20. Bouvet, M., Ellis, L., Nishizaki, M., Fujiwara, T., Liu, W., Bucana, C., Fang, B., Lee, J., and Roth, J. Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res., 58: 2288-2292, 1998.
21. Sun, Y., Wicha, M., and Leopold, W. Regulation of metastasis-related gene expression by p53: a potential clinical implication. Mol. Carcinog., 24: 25-28, 1999.